Page last updated: 2024-08-23

pravastatin and Angina, Unstable

pravastatin has been researched along with Angina, Unstable in 59 studies

Research

Studies (59)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	6 (10.17)	18.2507
2000's	47 (79.66)	29.6817
2010's	6 (10.17)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Colquhoun, DM; Glozier, N; Kirby, AC; Marschner, SL; Nestel, PJ; O'Neil, A; Oldenburg, B; Simes, J; Stewart, RAH; Tonkin, AM; White, HD	1
Barnes, EH; Blankenberg, S; Colquhoun, DM; Fournier, M; Nestel, PJ; Simes, J; Sullivan, DR; Tonkin, AM; White, HD	1
Blankenberg, S; Colquhoun, D; Hunt, D; Keech, AC; Mann, K; Nestel, P; Simes, J; Stewart, R; Sullivan, D; Thompson, P; Tonkin, A; West, M; White, HD	1
Omland, T	1
Braunwald, E; Cannon, CP; McCabe, CH; Murphy, SA; Wiviott, SD	1
Armani, A; Cannon, CP; McCabe, CH; Murphy, SA; Truong, QA	1
Fukui, K; Hibi, K; Kunishima, T; Michishita, I; Miyake, S; Morino, Y; Muramatsu, T; Nozato, T; Nozue, T; Onishi, Y; Sato, A; Takeyama, Y; Terashima, M; Tohyama, S; Umezawa, S; Yamamoto, S; Yamauchi, T	1
Bybee, KA; Kopecky, SL; LaBlanche, JM; Murphy, JG; Wright, RS	1
Kerensky, RA; Monroe, VS; Pepine, CJ; Rivera, E; Smith, KM	1
Arulchelvam, M; Baker, J; Beller, E; Best, J; Colquhoun, D; Hague, W; Hunt, D; Keech, A; Kirby, A; Simes, RJ; Tonkin, A	1
Origasa, H; Yokoyama, M	1
Cannon, CP	1
Belder, R; Braunwald, E; Cannon, CP; Hill, KA; Joyal, SV; McCabe, CH; Pfeffer, MA; Rader, DJ; Rouleau, JL; Skene, AM	1
Topol, EJ	1
Amerena, J; Campbell, TJ; Harris, PJ; Meredith, I; Sloman, JG; Thompson, PL	1
LeLorier, J; Paradis, JM	1
Gotto, AM	1
Miller, M	1
Auer, J; Eber, B; Weber, T	1
von Schacky, C	1
Farmer, JA	1
Andreadou, I; Aznaouridis, K; Cimponeriu, A; Karatzis, E; Lekakis, J; Mavrikakis, M; Papaioannou, TG; Papamichael, C; Protogerou, A	1
Han, ZH; Hu, R; Lü, Q; Ma, CS; Wu, XS; Zhao, Z	1
Cameron, JD; Hope, SA; Meredith, IT; Plunkett, JC; Worthley, SG	1
Braunwald, E; Cairns, R; Cannon, CP; Jackson, G; McCabe, CH; Ray, KK; Sacks, FM; Tonkin, AM	1
Braunwald, E; Cannon, CP; Morrow, DA; Pfeffer, MA; Ray, KK; Wiviott, SD	1
Braunwald, E; Cairns, R; Cannon, CP; Gibson, CM; Kirtane, AJ; McCabe, CH; Morrow, DA; Ray, KK; Ridker, PM; Rifai, N; Skene, AM	1
Fonarow, GC	1
Blazing, M; Braunwald, E; Califf, R; Cannon, CP; de Lemos, JA; McCabe, CH; Murphy, SA; Wiviott, SD	1
Denton, M; Eckermann, S; Friedlander, D; Glasziou, P; Hunt, D; Kirby, A; Magnus, P; Mulray, S; Sallaberger, M; Simes, J; Tonkin, AM; White, H	1
Braunwald, E; Cairns, R; Cannon, CP; Mega, JL; Morrow, DA; Murphy, S; Ridker, PM	1
Braunwald, E; Giugliano, RP	1
Alberti, A; Bergamasco, L; Brscic, E; Celeste, A; De Bernardi, A; Formato, L; Fuster, V; Moretti, C; Pucci, A; Sheiban, I; Trevi, G	1
Blazing, MA; Braunwald, E; Califf, RM; Cannon, CP; de Lemos, JA; McCabe, CH; Murphy, SA; Wiviott, SD	1
Fukunami, M; Hirayama, A; Hori, M; Ito, H; Kijima, Y; Kinjo, K; Koretsune, Y; Lim, YJ; Mizuno, H; Nakatani, D; Nanto, S; Nishino, M; Sato, H; Shimizu, M	1
Bickel, C; Blankenberg, S; Kirby, AC; Lubos, E; Münzel, TF; Nestel, PJ; Pollicino, C; Schnabel, R; Simes, RJ; Sullivan, D; Tiret, L; Tonkin, AM; West, MJ; White, HD	1
Fawcett, JP; Menkes, DB	1
Donaldson, C; Glasziou, PP; Hall, J; Simes, RJ	1
Gamble, G; Hart, H; MacMahon, S; Scott, J; Sharpe, N; Simes, J; White, H	1
Mahé, I	1
Agrawal, R; Arntz, HR; Fischer, F; Linderer, T; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W	1
Bertel, O; Darioli, R; Gutzwiller, F; Mordasini, R; Szucs, TD	1
Buckley, BM; Colwell, NS; Murphy, MB	1
Berger, K; März, W; Schäfer, JR; Szucs, TD	1
Agrawal, R; Arntz, HR; Fischer, F; Schnitzer, L; Schultheiss, HP; Stern, R; Wunderlich, W	1
Fruchter, O	1
Meilof, JF; Uitdehaag, BM	1
Colquhoun, D; Emberson, J; Hague, W; Hunt, D; Keech, A; Lane, G; MacMahon, S; Shaw, J; Simes, RJ; Thompson, PL; Tonkin, AM; White, HD	1
Bloom, JM	1
Uguccioni, M	1
Colquhoun, D; Friedlander, D; Glasziou, P; Harris, P; Marschner, IC; Simes, RJ; Singh, BB; Thompson, P; Tonkin, A; White, H	1
Den Hartog, FR; Rila, H; Schaafsma, HJ; Van Kalmthout, PM; Van Loenhout, TT; Verheugt, FW	1
Colquhoun, D; Hague, W; Hunt, D; Keech, A; Marschner, IC; Shaw, J; Simes, RJ; Stewart, RA; Sullivan, D; Thompson, P; Tonkin, A; White, H	1
Belder, R; Braunwald, E; Breen, J; Cannon, CP; McCabe, CH	1

Reviews

5 review(s) available for pravastatin and Angina, Unstable

Article	Year
Statin lipid-lowering therapy for acute myocardial infarction and unstable angina: efficacy and mechanism of benefit. Mayo Clinic proceedings, 2002, Volume: 77, Issue:10 Topics: Angina, Unstable; Anticholesteremic Agents; Evidence-Based Medicine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Randomized Controlled Trials as Topic	2002
Pharmacologic plaque passivation for the reduction of recurrent cardiac events in acute coronary syndromes. Journal of the American College of Cardiology, 2003, Feb-19, Volume: 41, Issue:4 Suppl S Topics: Abciximab; Acute Disease; Angina, Unstable; Antibodies, Monoclonal; C-Reactive Protein; Coronary Artery Disease; Coronary Thrombosis; Disease Progression; Endothelium, Vascular; Enoxaparin; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunoglobulin Fab Fragments; Macrophages; Myocardial Infarction; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pravastatin; Randomized Controlled Trials as Topic; Secondary Prevention; Severity of Illness Index	2003
The next step in cardiovascular protection. Atherosclerosis. Supplements, 2003, Volume: 4, Issue:5 Topics: Angina, Unstable; Anti-Bacterial Agents; Anticholesteremic Agents; Atorvastatin; Chlamydia Infections; Chlamydophila pneumoniae; Cholesterol, LDL; Clinical Trials as Topic; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Pyrroles; Secondary Prevention	2003
In-hospital initiation of statin therapy in acute coronary syndromes: maximizing the early and long-term benefits. Chest, 2005, Volume: 128, Issue:5 Topics: Angina, Unstable; Atorvastatin; Cholesterol, HDL; Cholesterol, LDL; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Myocardial Ischemia; Pravastatin; Pyrroles; Syndrome; Treatment Outcome	2005
The year in non-ST-segment elevation acute coronary syndromes. Journal of the American College of Cardiology, 2006, Jul-18, Volume: 48, Issue:2 Topics: Angina, Unstable; Angioplasty, Balloon, Coronary; Atorvastatin; Biomarkers; Clopidogrel; Coronary Vessels; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Multivariate Analysis; Myocardial Infarction; Platelet Aggregation Inhibitors; Pravastatin; Prognosis; Pyrroles; Risk Assessment; Stents; Syndrome; Thrombolytic Therapy; Ticlopidine	2006

Trials

29 trial(s) available for pravastatin and Angina, Unstable

Article	Year
Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease. Arteriosclerosis, thrombosis, and vascular biology, 2013, Volume: 33, Issue:12 Topics: Aged; Angina, Unstable; Australia; Biomarkers; Coronary Disease; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoprotein(a); Male; Middle Aged; Myocardial Infarction; New Zealand; Pravastatin; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Up-Regulation	2013
Association of contemporary sensitive troponin I levels at baseline and change at 1 year with long-term coronary events following myocardial infarction or unstable angina: results from the LIPID Study (Long-Term Intervention With Pravastatin in Ischaemic Journal of the American College of Cardiology, 2014, Feb-04, Volume: 63, Issue:4 Topics: Adult; Aged; Angina, Unstable; Biomarkers; C-Reactive Protein; Coronary Disease; Follow-Up Studies; Heart Failure; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Middle Aged; Multivariate Analysis; Myocardial Infarction; Natriuretic Peptide, Brain; Pravastatin; Risk Assessment; Stroke; Troponin I	2014
Reduction in recurrent cardiovascular events with intensive lipid-lowering statin therapy compared with moderate lipid-lowering statin therapy after acute coronary syndromes from the PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection T Journal of the American College of Cardiology, 2009, Dec-15, Volume: 54, Issue:25 Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cholesterol; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Pyrroles; Regression Analysis; Secondary Prevention; Stroke	2009
Benefit of intensive statin therapy in women: results from PROVE IT-TIMI 22. Circulation. Cardiovascular quality and outcomes, 2011, Volume: 4, Issue:3 Topics: Acute Coronary Syndrome; Aged; Angina, Unstable; Atorvastatin; Biomarkers; Dose-Response Relationship, Drug; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Sex Characteristics; Stroke; Treatment Outcome	2011
Comparison of change in coronary atherosclerosis in patients with stable versus unstable angina pectoris receiving statin therapy (from the Treatment With Statin on Atheroma Regression Evaluated by Intravascular Ultrasound With Virtual Histology [TRUTH] s The American journal of cardiology, 2013, Apr-01, Volume: 111, Issue:7 Topics: Aged; Angina, Stable; Angina, Unstable; Biomarkers; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Japan; Lipids; Male; Plaque, Atherosclerotic; Pravastatin; Quinolines; Regression Analysis; Treatment Outcome; Ultrasonography, Interventional	2013
Secondary prevention of cardiovascular events with long-term pravastatin in patients with diabetes or impaired fasting glucose: results from the LIPID trial. Diabetes care, 2003, Volume: 26, Issue:10 Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Blood Glucose; Cardiovascular Diseases; Coronary Artery Disease; Coronary Restenosis; Diabetes Mellitus, Type 2; Fasting; Female; Follow-Up Studies; Glucose Intolerance; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Pravastatin; Risk Factors; Stroke; Treatment Outcome	2003
Effects of eicosapentaenoic acid on cardiovascular events in Japanese patients with hypercholesterolemia: rationale, design, and baseline characteristics of the Japan EPA Lipid Intervention Study (JELIS). American heart journal, 2003, Volume: 146, Issue:4 Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Chemotherapy, Adjuvant; Coronary Artery Disease; Death, Sudden, Cardiac; Eicosapentaenoic Acid; Fatty Acids, Unsaturated; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Japan; Male; Middle Aged; Myocardial Infarction; Pravastatin; Prospective Studies; Simvastatin	2003
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. The New England journal of medicine, 2004, Apr-08, Volume: 350, Issue:15 Topics: Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Proportional Hazards Models; Pyrroles	2004
Effect of pravastatin compared with placebo initiated within 24 hours of onset of acute myocardial infarction or unstable angina: the Pravastatin in Acute Coronary Treatment (PACT) trial. American heart journal, 2004, Volume: 148, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Angina, Unstable; Cholesterol; Double-Blind Method; Female; Heart Diseases; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Recurrence; Risk	2004
Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina. International journal of cardiology, 2005, May-11, Volume: 101, Issue:1 Topics: Aged; Angina, Unstable; Brachial Artery; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipid Peroxidation; Male; Malondialdehyde; Middle Aged; Nuclear Proteins; Oxidative Stress; Placebos; Pravastatin	2005
[Clinical study of pravastatin with different dosage in early admission period in patients with unstable angina]. Zhonghua xin xue guan bing za zhi, 2005, Volume: 33, Issue:1 Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Female; Follow-Up Studies; Humans; Inpatients; Male; Middle Aged; Pravastatin; Prospective Studies	2005
Systemic inflammatory markers in acute coronary syndrome: association with cardiovascular risk factors and effect of early lipid lowering. Coronary artery disease, 2005, Volume: 16, Issue:7 Topics: Aged; Angina, Unstable; Biomarkers; Double-Blind Method; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Inflammation; Logistic Models; Male; Middle Aged; Myocardial Infarction; Pravastatin; Risk Factors	2005
Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology, 2005, Oct-18, Volume: 46, Issue:8 Topics: Acute Disease; Angina, Unstable; Atorvastatin; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome; Time Factors	2005
Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. Journal of the American College of Cardiology, 2005, Oct-18, Volume: 46, Issue:8 Topics: Acute Disease; Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cross-Sectional Studies; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pravastatin; Pyrroles; Risk Factors; Syndrome	2005
Cost-effectiveness of cholesterol-lowering therapy with pravastatin in patients with previous acute coronary syndromes aged 65 to 74 years compared with younger patients: results from the LIPID study. American heart journal, 2006, Volume: 151, Issue:6 Topics: Acute Disease; Adult; Age Factors; Aged; Angina, Unstable; Anticholesteremic Agents; Cost-Benefit Analysis; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Pravastatin; Survival Rate; Syndrome	2006
Cholesterol, C-reactive protein, and cerebrovascular events following intensive and moderate statin therapy. Journal of thrombosis and thrombolysis, 2006, Volume: 22, Issue:1 Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cholesterol; Epidemiologic Methods; Female; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Stroke	2006
In vivo coronary plaque histology in patients with stable and acute coronary syndromes: relationships with hyperlipidemic status and statin treatment. Atherosclerosis, 2007, Volume: 194, Issue:1 Topics: Acute Disease; Aged; Angina, Unstable; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Atherectomy, Coronary; Atorvastatin; Coronary Artery Disease; Coronary Vessels; Female; Glycophorins; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipidemias; Immunohistochemistry; Male; Middle Aged; Pravastatin; Pyrroles	2007
Effect of intensive lipid-lowering therapy on mortality after acute coronary syndrome (a patient-level analysis of the Aggrastat to Zocor and Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 trials). The American journal of cardiology, 2007, Oct-01, Volume: 100, Issue:7 Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cholesterol, LDL; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Pravastatin; Pyrroles; Simvastatin; Tirofiban; Treatment Outcome; Tyrosine	2007
Effect of early use of low-dose pravastatin on major adverse cardiac events in patients with acute myocardial infarction: the OACIS-LIPID Study. Circulation journal : official journal of the Japanese Circulation Society, 2008, Volume: 72, Issue:1 Topics: Aged; Angina, Unstable; Death; Female; Hospitalization; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Secondary Prevention; Stroke; Treatment Outcome	2008
Design features and baseline characteristics of the LIPID (Long-Term Intervention with Pravastatin in Ischemic Disease) Study: a randomized trial in patients with previous acute myocardial infarction and/or unstable angina pectoris. The American journal of cardiology, 1995, Sep-01, Volume: 76, Issue:7 Topics: Adult; Aged; Angina, Unstable; Australia; Cholesterol; Double-Blind Method; Female; Humans; Length of Stay; Male; Middle Aged; Myocardial Infarction; Pravastatin; Reference Values; Research Design; Survival Rate	1995
Design of a cost-effectiveness study within a randomized trial: the LIPID Trial for Secondary Prevention of IHD. Long-term Intervention with Pravastatin in Ischemic Heart disease. Controlled clinical trials, 1997, Volume: 18, Issue:5 Topics: Absenteeism; Angina, Unstable; Anticholesteremic Agents; Australia; Coronary Disease; Cost-Benefit Analysis; Double-Blind Method; Health Resources; Humans; Myocardial Infarction; New Zealand; Pravastatin; Quality-Adjusted Life Years; Recurrence; Research Design; Survival Analysis	1997
Effects of lowering average of below-average cholesterol levels on the progression of carotid atherosclerosis: results of the LIPID Atherosclerosis Substudy. LIPID Trial Research Group. Circulation, 1998, May-12, Volume: 97, Issue:18 Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Apolipoproteins A; Apolipoproteins B; Arteriosclerosis; Carotid Artery, Common; Carotid Stenosis; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cohort Studies; Disease Progression; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; New Zealand; Pravastatin; Risk Factors; Treatment Outcome; Triglycerides; Ultrasonography	1998
[Short- and long-term effects of intensified versus conventional antilipidemic therapy in patients with coronary heart disease. Results from the Lipid-Coronary Artery Disease (L-CAD) Study]. Zeitschrift fur Kardiologie, 1999, Volume: 88, Issue:8 Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Cholesterol, LDL; Cholestyramine Resin; Coronary Disease; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Niacin; Pravastatin; Prospective Studies; Treatment Outcome	1999
[Pharmacoeconomic evaluation of pravastatin in coronary secondary prevention in patients with myocardial infarct or unstable angina pectoris. An analysis based on the LIPID Study]. Praxis, 2000, Apr-27, Volume: 89, Issue:18 Topics: Angina, Unstable; Anticholesteremic Agents; Cost-Benefit Analysis; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Myocardial Infarction; Pravastatin; Recurrence	2000
Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study). The American journal of cardiology, 2000, Dec-15, Volume: 86, Issue:12 Topics: Adult; Aged; Angina, Unstable; Angioplasty, Balloon, Coronary; Anticholesteremic Agents; Chemoprevention; Chi-Square Distribution; Cholesterol, LDL; Cholestyramine Resin; Confidence Intervals; Coronary Angiography; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Drug Combinations; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Niacin; Odds Ratio; Peripheral Vascular Diseases; Pravastatin; Regression Analysis; Statistics, Nonparametric; Stroke; Survival Rate; Treatment Outcome	2000
Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study. Lancet (London, England), 2000, Dec-02, Volume: 356, Issue:9245 Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pravastatin; Single-Blind Method; Survival Analysis; Survival Rate; Treatment Outcome; Triglycerides	2000
Long-term risk stratification for survivors of acute coronary syndromes. Results from the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Study. LIPID Study Investigators. Journal of the American College of Cardiology, 2001, Volume: 38, Issue:1 Topics: Aged; Angina, Unstable; Anticholesteremic Agents; Coronary Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Multivariate Analysis; Myocardial Infarction; Pravastatin; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Syndrome	2001
Pravastatin in acute ischaemic syndromes: results of a randomised placebo-controlled trial. International journal of clinical practice, 2001, Volume: 55, Issue:5 Topics: Acute Disease; Angina, Unstable; Anticholesteremic Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Pravastatin; Survival Analysis; Treatment Outcome	2001
Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up. Lancet (London, England), 2002, Apr-20, Volume: 359, Issue:9315 Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Coronary Disease; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Risk; Survival Analysis; Time Factors; Treatment Outcome	2002

Other Studies

25 other study(ies) available for pravastatin and Angina, Unstable

Article	Year
Persistent psychological distress and mortality in patients with stable coronary artery disease. Heart (British Cardiac Society), 2017, Volume: 103, Issue:23 Topics: Adult; Aged; Angina, Unstable; Australia; Coronary Artery Disease; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Myocardial Infarction; New Zealand; Odds Ratio; Pravastatin; Prognosis; Proportional Hazards Models; Risk Assessment; Risk Factors; Severity of Illness Index; Stress, Psychological; Surveys and Questionnaires; Time Factors	2017
Cardiac troponins: a tool for a personalized medicine strategy in stable coronary artery disease? Journal of the American College of Cardiology, 2014, Feb-04, Volume: 63, Issue:4 Topics: Angina, Unstable; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Troponin I	2014
Rosuvastatin for cardiovascular prevention: too many uncertainties. Prescrire international, 2009, Volume: 18, Issue:102 Topics: Aged; Angina, Unstable; Anticholesteremic Agents; Cardiovascular Diseases; Diabetes Mellitus; Double-Blind Method; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Pravastatin; Pyrimidines; Randomized Controlled Trials as Topic; Rosuvastatin Calcium; Simvastatin; Stroke; Sulfonamides; Uncertainty	2009
Intensive statin therapy--a sea change in cardiovascular prevention. The New England journal of medicine, 2004, Apr-08, Volume: 350, Issue:15 Topics: Angina, Unstable; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Pyrroles	2004
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. The New England journal of medicine, 2004, Aug-12, Volume: 351, Issue:7 Topics: Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Patient Dropouts; Pravastatin; Pyrroles	2004
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. The New England journal of medicine, 2004, Aug-12, Volume: 351, Issue:7 Topics: Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Pyrroles	2004
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. The New England journal of medicine, 2004, Aug-12, Volume: 351, Issue:7 Topics: Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Pyrroles; Triglycerides	2004
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. The New England journal of medicine, 2004, Aug-12, Volume: 351, Issue:7 Topics: Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Coronary Disease; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin; Pyrroles	2004
[Statin therapy in patients with acute coronary syndrome. "Prove-it" study]. Der Internist, 2004, Volume: 45, Issue:12 Topics: Angina, Unstable; Anticholesteremic Agents; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Myocardial Infarction; Pravastatin; Proportional Hazards Models; Pyrroles; Randomized Controlled Trials as Topic; Syndrome; Treatment Outcome	2004
Intensive versus moderate lipid lowering with statins in acute coronary syndromes. Current atherosclerosis reports, 2005, Volume: 7, Issue:2 Topics: Adolescent; Angina, Unstable; Anticholesteremic Agents; Atorvastatin; Cholesterol, LDL; Dose-Response Relationship, Drug; Heptanoic Acids; Humans; Hyperlipidemias; Multicenter Studies as Topic; Myocardial Infarction; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Risk Factors; Survival Rate; Treatment Outcome	2005
Can low-density lipoprotein be too low? The safety and efficacy of achieving very low low-density lipoprotein with intensive statin therapy: a PROVE IT-TIMI 22 substudy. Journal of the American College of Cardiology, 2005, Oct-18, Volume: 46, Issue:8 Topics: Acute Disease; Angina, Unstable; Atorvastatin; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Pravastatin; Pyrroles; Syndrome	2005
A tale of two trials: a comparison of the post-acute coronary syndrome lipid-lowering trials A to Z and PROVE IT-TIMI 22. Circulation, 2006, Mar-21, Volume: 113, Issue:11 Topics: Aged; Angina, Unstable; Atorvastatin; C-Reactive Protein; Cardiovascular Diseases; Case Management; Chemical and Drug Induced Liver Injury; Comorbidity; Confounding Factors, Epidemiologic; Dose-Response Relationship, Drug; Endpoint Determination; Female; Heptanoic Acids; Hospitalization; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Tables; Lipids; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design; Risk; Risk Factors; Simvastatin; Stroke; Tirofiban; Treatment Outcome; Tyrosine	2006
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID study. European heart journal, 2008, Volume: 29, Issue:7 Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Biomarkers; C-Reactive Protein; Case-Control Studies; Coronary Angiography; Female; Humans; Leukocyte Count; Male; Middle Aged; Myocardial Infarction; Natriuretic Peptide, Brain; Peptide Fragments; Pravastatin; Prognosis; Risk Factors; Tissue Inhibitor of Metalloproteinase-1	2008
Does cholesterol depletion have adverse effects on blood rheology? Angiology, 1994, Volume: 45, Issue:3 Topics: Angina, Unstable; Blood Viscosity; Cholesterol; Erythrocyte Deformability; Erythrocytes; Female; Hematocrit; Hemorheology; Humans; Male; Microscopy, Electron, Scanning; Middle Aged; Myocardial Infarction; Pravastatin	1994
[What is the role of pravastatin in the secondary prevention of coronary disease?]. Presse medicale (Paris, France : 1983), 1999, Apr-03, Volume: 28, Issue:13 Topics: Adult; Aged; Angina, Unstable; Coronary Disease; Female; Humans; Male; Middle Aged; Myocardial Infarction; Pravastatin; Recurrence	1999
Unstable angina pectoris. The New England journal of medicine, 2000, Jun-01, Volume: 342, Issue:22 Topics: Acute Disease; Angina, Unstable; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Pravastatin; Risk Factors	2000
[Cost effectiveness of pravastatin in secondary coronary prevention in patients with myocardial infarct or unstable angina in Germany. An analysis on the basis of the LIPID trial]. Herz, 2000, Volume: 25, Issue:5 Topics: Angina, Unstable; Anticholesteremic Agents; Clinical Trials as Topic; Coronary Disease; Cost-Benefit Analysis; Costs and Cost Analysis; Female; Germany; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Life Expectancy; Male; Middle Aged; Myocardial Infarction; Pravastatin; Quality of Life	2000
Pravastatin therapy and the risk of stroke. The New England journal of medicine, 2000, Dec-21, Volume: 343, Issue:25 Topics: Angina, Unstable; Anticholesteremic Agents; Humans; Myocardial Infarction; Pravastatin; Risk Factors; Stroke	2000
Pravastatin therapy and the risk of stroke. The New England journal of medicine, 2000, Dec-21, Volume: 343, Issue:25 Topics: Angina, Unstable; Anticholesteremic Agents; Humans; Myocardial Infarction; Pravastatin; Risk Factors; Stroke	2000
Pravastatin and coronary heart disease. Lancet (London, England), 2001, Mar-31, Volume: 357, Issue:9261 Topics: Angina, Unstable; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Myocardial Infarction; Pravastatin	2001
[Effects of pravastatin in 3260 patients with unstable angina: results from the LIPID study]. Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology, 2001, Volume: 2, Issue:3 Topics: Angina, Unstable; Anticholesteremic Agents; Clinical Trials as Topic; Humans; Pravastatin	2001
[Acute coronary syndrome. Early lipid reduction decreases risk of recurrence]. MMW Fortschritte der Medizin, 2001, Apr-19, Volume: 143, Issue:16 Topics: Angina, Unstable; Cholesterol, LDL; Humans; Hypercholesterolemia; Myocardial Infarction; Pravastatin; Randomized Controlled Trials as Topic; Recurrence	2001
[CSE inhibitors after coronary event. How soon administered?]. MMW Fortschritte der Medizin, 2001, May-31, Volume: 143, Issue:22 Topics: Angina, Unstable; Anticholesteremic Agents; Clinical Trials as Topic; Combined Modality Therapy; Drug Administration Schedule; Humans; Myocardial Infarction; Pravastatin	2001
Relationship between lipid levels and clinical outcomes in the Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) Trial: to what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels? Circulation, 2002, Mar-12, Volume: 105, Issue:10 Topics: Adult; Aged; Angina, Unstable; Anticholesteremic Agents; Apolipoprotein A-I; Apolipoproteins B; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Coronary Disease; Endpoint Determination; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipids; Middle Aged; Myocardial Infarction; Pravastatin; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Time; Treatment Outcome; Triglycerides	2002
Design of the Pravastatin or Atorvastatin Evaluation and Infection Therapy (PROVE IT)-TIMI 22 trial. The American journal of cardiology, 2002, Apr-01, Volume: 89, Issue:7 Topics: Angina, Unstable; Anti-Infective Agents; Anticholesteremic Agents; Atorvastatin; Chlamydophila Infections; Chlamydophila pneumoniae; Cholesterol, LDL; Double-Blind Method; Fluoroquinolones; Gatifloxacin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Multicenter Studies as Topic; Myocardial Infarction; Pneumonia, Bacterial; Pravastatin; Pyrroles; Randomized Controlled Trials as Topic; Research Design	2002